Search
for
Sort by
Research 331–360 of 1000+
- Case Report: Reversal of Long-Standing Refractory Diffuse Non-Scarring Alopecia Due to Systemic Lupus Erythematosus Following Treatment With Tofacitinib
- Gut instinct: Using tofacitinib to treat alopecia areata in the context of comorbid inflammatory bowel disease
- Frontal fibrosing alopecia: a disease fascinating for the researcher, disappointing for the clinician and distressing for the patient
- The Relative Efficacy and Safety of Monotherapies for Alopecia Areata: A Network Meta‐Analysis Study
- II Consensus of the Brazilian Society of Dermatology for the treatment of alopecia areata
- Refractory alopecia in lupus treated with tofacitinib — a case-based review
- Two phase III trials of baricitinib for alopecia areata: a critically appraised research paper
- Acne exacerbation after tofacitinib treatment for alopecia areata
- Childhood Alopecia Areata: An Overview of Treatment and Recent Patents
- What’s New in Hair Loss
- Integrated single-cell chromatin and transcriptomic analyses of peripheral immune cells in patients with alopecia areata
- Taiwanese Dermatological Association consensus on the diagnosis and management of alopecia areata
- Ruxolitinib 1.5% Topical Cream for the Treatment of Pediatric Alopecia Areata
- Biologics in the management of childhood atopic dermatitis
- Tofacitinib as a pragmatic treatment choice for alopecia areata: A retrospective review
- The Role of Tofacitinib in the Management of Alopecia Totalis
- Successful Treatment of Severe Alopecia Areata With Oral or Topical Tofacitinib.
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Real-world assessment of ritlecitinib in patients with severe alopecia areata: a 24-week multicentre retrospective study
- Relapse of Alopecia Areata Responders After Tofacitinib Withdrawal: A Retrospective Study of 59 Patients
- FDA approval of Deuruxolitinib: A New Treatment Option for Severe Alopecia Areata
- The Importance of Readability: A Guide to Understanding Alopecia Areata through Multilingual Online Resources
- SDRIFE Induced by Tofacitinib
- Real-world experience quantifying access to JAK inhibitor care for alopecia areata patients: a patient-centered survey study
- Upadacitinib for management of recalcitrant alopecia areata: A retrospective case series
- Alopecias in humans: biology, pathomechanisms and emerging therapies
- LB785 Efficacy and safety of baricitinib in adults with Alopecia Areata: Phase 3 results from a randomized controlled trial (BRAVE-AA1)
- Recent Insight on the Management of Lupus Erythematosus Alopecia
- Improvement of Psoriasis, Psoriatic Arthritis, and Alopecia Universalis during Treatment with Tofacitinib: A Case Report
- 691 Topical curcumin promotes induction of the murine hair cycle